By Pietro Lombardi 

Lonza Group AG said Wednesday that it will add around 200 jobs at its site in Visp, Switzerland, thanks to a long-term collaboration with a global biopharma company.

The Swiss life-sciences company said the site will host new manufacturing space and related services able to handle materials for cancer therapies. Operations should start at the end of 2022.


Write to Pietro Lombardi at; @pietrolombard10


(END) Dow Jones Newswires

December 02, 2020 01:54 ET (06:54 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.